top of page
Home
Contact
Research
Basilea
About
Services
Partners
Sign up
Blog
Â
Use tab to navigate through the menu items.
All Posts
Search
Brian White
Sep 24
Basilea - Fosmanogepix Phase 3 begins
Andrew Keith
Sep 19
Basilea - Significant BARDA funding
Brian White
Sep 6
Further Cresemba sales success
Andrew Keith
Aug 29
Basilea research report
Brian White
Aug 27
Cresemba's market exclusivity extension
Brian White
Aug 13
Gaining momentum in H1 2024
Brian White
May 16
Basilea - Cresemba APAC milestone
Brian White
May 3
Basilea - Fleshing out Zevtera
Brian White
Apr 4
Zevtera FDA approval
Andrew Keith
Feb 28
Basilea research report
Brian White
Feb 13
Basilea full-year results - Strong execution
Brian White
Jan 19
Basilea - Cresemba LatAm milestone
Brian White
Jan 15
Basilea adds another antibiotic programme
Brian White
Jan 5
Basilea portfolio update
Brian White
Dec 11, 2023
Basilea - Paediatric Cresemba approval
Brian White
Nov 13, 2023
Basilea - Fosmanogepix acquired
Brian White
Oct 31, 2023
Basilea - Novel antibacterial acquired
Andrew Keith
Oct 19, 2023
Basilea antifungal acquistion
Andrew Keith
Oct 2, 2023
FDA accepts ceftobiprole's NDA
Brian White
Sep 28, 2023
Key ceftobiprole data published
1
2
3
4
5
bottom of page
